Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 20/20 | 0.46 |
| ▸ | CA2 | P00918 | 20/20 | 0.46 |
| ▸ | CA4 | P22748 | 11/20 | 0.46 |
| ▸ | CA12 | O43570 | 5/20 | 0.46 |
| ▸ | CA9 | Q16790 | 5/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19177279 | 0.80 | CA1 (0.53) | CA1CA2CA4CA12CA9 | |
| SCHEMBL2597556 | 0.80 | TDP1 (0.44) | CA1CA2CA4CA12CA9 | |
| SCHEMBL668012 | 0.79 | TDP1 (0.41) | CA1CA2CA4CA12CA9 | |
| SCHEMBL7367941 | 0.75 | KCNH2 (0.51) | CA1CA2CA4CA12CA9 | |
| SCHEMBL1230833 | 0.74 | HSD17B10 (0.39) | CA1CA2CA4CA12CA9 | |
| SCHEMBL6047697 | 0.73 | CA1 (0.64) | CA1CA2CA4CA12CA9 | |
| SCHEMBL15499792 | 0.72 | CA1 (0.75) | CA1CA2CA4CA12CA9 | |
| SCHEMBL13523700 | 0.72 | CA1 (0.66) | CA1CA2CA4CA12CA9 | |
| SCHEMBL5322282 | 0.71 | CA1 (0.44) | CA1CA2CA4CA12CA9 | |
| SCHEMBL16113686 | 0.68 | TDP1 (0.58) | CA1CA2CA4CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007113386-A1 | PEPTIDE CONJUGATES | KARYON-CTT LTD (FI) | 2007-10-11 | — | — | WO | disclosed |
| US-20070231258-A1 | Peptide conjugates | KARYON CTT LTD. (FI) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070231258-A1 | Peptide conjugates | PTMS, QPCT, CTH | CA1 793/4885CA2 3250/4885CA4 1920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.